text: Clinical practice guidelines from NICE and the American Association for the Study of<unk>  Diseases (AASLD) direct management. The available guidelines have been compared and summarized.
  Weight loss, withdrawal of hepatotoxic agents, and management of underlying insulin resistance/metabolic syndrome is the mainstay of treatment in<unk> -alcoholic<unk><unk>  disease (NAFLD).
option_0: Non-alcoholic fatty liver disease medical therapy
option_1: Alcoholic liver disease medical therapy
option_2: Hemochromatosis medical therapy
option_3: Fatty liver medical therapy
option_4: Alcoholic hepatitis medical therapy
option_5: Primary biliary cirrhosis medical therapy
option_6: Autoimmune hepatitis medical therapy
option_7: Alcoholic liver disease secondary prevention